● Independent ● Community Verified ●

Dosage & Reconstitution Guide

TB-500 Dosage & Reconstitution Guide

A clear educational guide covering TB-500 reconstitution, unit conversions, gradual protocol examples, supplies, storage, injection technique, tissue repair research notes and safety considerations.

Important: This content is for educational and research reference only. It is not medical advice, dosing advice or a treatment recommendation. Peptide Hub Australia does not sell peptides and does not recommend human use.

Quickstart Highlights

  • Peptide: TB-500
  • Common vial size: 10mg
  • Example reconstitution: 3.0mL bacteriostatic water
  • Resulting concentration: approximately 3.33mg/mL
  • U-100 syringe maths: 1 unit = 0.01mL = approximately 33.3mcg
  • Common research range discussed: 500mcg to 1,000mcg daily
  • Common cycle discussed: 8-12 weeks, with optional extension to 16 weeks
  • Storage after mixing: refrigerate at 2-8°C and do not freeze reconstituted solution

What is TB-500?

TB-500 is a synthetic peptide fragment corresponding to the active region of thymosin beta-4, a naturally occurring protein involved in tissue repair, cell migration and regeneration pathways.

In research discussions, TB-500 is most commonly associated with tissue repair, wound healing, angiogenesis, collagen deposition, inflammation pathways and recovery-related animal studies.

TB-500 Reconstitution Example

The example below is based on a common 10mg TB-500 vial mixed with 3.0mL bacteriostatic water.

Reconstitution Maths

10mg ÷ 3.0mL = 3.33mg/mL
3.33mg/mL = 3,333mcg/mL
1 unit on a U-100 syringe = 0.01mL
3,333mcg/mL × 0.01mL = approximately 33.3mcg per unit

TB-500 Unit Conversion Table

Target Amount U-100 Units mL
500mcg15 units0.15mL
600mcg18 units0.18mL
750mcg23 units0.23mL
1,000mcg / 1mg30 units0.30mL

Standard Gradual Research Example

This example uses a 10mg vial reconstituted with 3.0mL bacteriostatic water, giving a concentration of approximately 3.33mg/mL.

Phase Daily Amount U-100 Units mL
Weeks 1-2500mcg15 units0.15mL
Weeks 3-4600mcg18 units0.18mL
Weeks 5-8750mcg23 units0.23mL
Weeks 9-121,000mcg30 units0.30mL
Research note: This is a research-style measurement example only. TB-500 is commonly discussed in tissue repair and wound healing research, but this page should not be treated as personal dosing advice or an instruction to use it.

Frequency and Timing Notes

TB-500 is commonly discussed as a once-daily subcutaneous compound in the source protocol. The example gradually increases from 500mcg daily toward 1,000mcg daily.

Timing is usually flexible. The key practical point is consistency, site rotation and careful tracking of the amount used, injection site and observations.

Reconstitution Steps

  1. Confirm the vial size before calculating concentration.
  2. Draw 3.0mL bacteriostatic water using sterile technique.
  3. Inject the bacteriostatic water slowly down the inside wall of the vial.
  4. Avoid blasting the powder directly and avoid creating foam.
  5. Gently swirl or roll the vial until dissolved.
  6. Do not shake.
  7. Label the vial with the reconstitution date and concentration.
  8. Store refrigerated at 2-8°C, protected from light.

Supplies Needed

TB-500 Vials

  • 8-week example: approximately 4 × 10mg vials.
  • 12-week example: approximately 7 × 10mg vials.
  • 16-week example: approximately 10 × 10mg vials.

Insulin Syringes

  • Daily example: 7 syringes per week.
  • 8 weeks: approximately 56 syringes.
  • 12 weeks: approximately 84 syringes.
  • 16 weeks: approximately 112 syringes.

Bacteriostatic Water

  • Per 10mg vial: 3.0mL bacteriostatic water.
  • 8-week example: 4 vials × 3.0mL = 12mL total, so 2 × 10mL bottles may be needed.
  • 12-week example: 7 vials × 3.0mL = 21mL total, so 3 × 10mL bottles may be needed.
  • 16-week example: 10 vials × 3.0mL = 30mL total, so 3 × 10mL bottles may be needed.

Alcohol Swabs

  • Per administration: one swab for the vial stopper and one for the injection site.
  • Per week: approximately 14 swabs based on daily administration.
  • 8 weeks: around 112 swabs, so 2 × 100-count boxes may be needed.
  • 12 weeks: around 168 swabs, so 2 × 100-count boxes may be needed.
  • 16 weeks: around 224 swabs, so 3 × 100-count boxes may be needed.

Protocol Overview

  • Goal discussed in research: tissue repair, wound healing and angiogenesis pathways.
  • Schedule example: once-daily subcutaneous administration.
  • Common amount discussed: 500-1,000mcg daily with gradual titration.
  • Approximate weekly amount: around 5mg per week on average in the source protocol.
  • Example reconstitution: 3.0mL bacteriostatic water per 10mg vial.
  • Concentration: approximately 3.33mg/mL.
  • Cycle length: 8-12 weeks is commonly discussed, with optional extension to 16 weeks.
  • Storage: lyophilised frozen, reconstituted refrigerated and not frozen after mixing.

Example Dosing Protocol

  • Start: 500mcg daily.
  • Titration: increase by around 100-150mcg every 2 weeks as tolerated.
  • Target example: 750-1,000mcg daily by weeks 5-12.
  • Frequency: once daily in the source protocol.
  • Timing: any consistent time of day is commonly discussed.

How TB-500 Works

TB-500 represents the active N-terminal fragment of thymosin beta-4. The source protocol identifies the heptapeptide sequence as Ac-LKKTETQ.

This region is discussed for actin-binding and cell-migration properties. Preclinical research commonly links TB-500 and thymosin beta-4 fragments with angiogenesis, wound healing, cell motility and tissue regeneration pathways.

The source also notes research suggesting TB-500 may act as a prodrug, cleaving to an active pentapeptide metabolite that may drive biological activity.

Potential Benefits Discussed in Research

  • Tissue repair research
  • Wound healing pathway discussions
  • Angiogenesis research
  • Cell migration and actin-binding pathway discussions
  • Collagen deposition research
  • Inflammation and fibrosis research in animal models
  • Veterinary and equine sports medicine research contexts
  • Thymosin beta-4 fragment research

Reported Side Effects and Limitations

  • Mild injection-site redness
  • Tenderness or local irritation
  • Human safety data is limited
  • No large-scale clinical trials have been completed for TB-500 specifically
  • Not FDA-approved for human administration
  • Prohibited in competitive sports under WADA rules
  • Not a guaranteed treatment for injury, inflammation, wound healing or tissue repair
Important safety note: TB-500 should not be presented as a proven injury-repair, muscle-repair, tendon-healing, wound-healing or performance compound. It is not approved for human use and is prohibited in competitive sport under WADA regulations.

Storage Instructions

  • Lyophilised powder: store frozen at around -20°C in dry, dark conditions.
  • After reconstitution: refrigerate at 2-8°C.
  • Use window: commonly discussed as within 28 days when mixed with bacteriostatic water.
  • Do not freeze after mixing: freezing reconstituted solution may damage peptide integrity.
  • Protect from light: keep the vial away from unnecessary light exposure.
  • Avoid: heat, sunlight, moisture, contamination and repeated freeze-thaw cycles.
  • Practical note: allow vials to reach room temperature before opening to reduce condensation uptake.

Injection Technique Notes

This section is general educational information only. It is not personal injection instruction.

  • Use a new sterile insulin syringe for each administration.
  • Clean the vial stopper and injection site with alcohol and allow both to dry completely.
  • Common subcutaneous sites discussed include abdomen, thighs and upper arms.
  • Rotate injection sites systematically to reduce local irritation and lipohypertrophy risk.
  • Pinch a skinfold and insert into subcutaneous tissue at an appropriate angle.
  • Do not aspirate for subcutaneous injections.
  • Inject slowly and steadily.
  • Wait 5-10 seconds before withdrawing the needle to help reduce leakage.
  • Withdraw the needle at the same angle and apply gentle pressure if needed.
  • Do not rub the site vigorously.
  • Dispose of used sharps safely in a sharps container.

Lifestyle Factors That May Matter

  • Protein intake: adequate protein supports normal tissue repair and recovery processes.
  • Training load: avoid overtraining during injury recovery research contexts.
  • Physical activity: appropriate movement and rehab-style activity may support recovery goals.
  • Sleep: 7-9 hours of quality sleep supports natural repair mechanisms.
  • Stress management: chronic stress may interfere with recovery and inflammation balance.
  • Tracking: documenting amount, date, site and observations can make tolerance patterns easier to review.

Use the Peptide Calculator

If your vial size, water volume or target amount is different, use the Peptide Hub Australia calculator to work out concentration, mL and syringe units.

Calculate TB-500 Units

Enter your vial size, BAC water amount and target amount to calculate concentration and syringe units.

Open Peptide Calculator

Where to Compare TB-500 Suppliers

Peptide Hub Australia does not sell TB-500 or any other peptides. We compare Australian peptide vendors, package audits, pricing and supplier information to help users review the market more clearly.

Frequently Asked Questions

How much BAC water do you add to a 10mg TB-500 vial?

A common educational example is 3.0mL bacteriostatic water added to a 10mg vial, creating a concentration of approximately 3.33mg/mL.

How many units is 500mcg of TB-500?

If a 10mg vial is mixed with 3.0mL, 500mcg is approximately 15 units on a U-100 insulin syringe, equal to around 0.15mL.

How many units is 750mcg of TB-500?

If a 10mg vial is mixed with 3.0mL, 750mcg is approximately 23 units on a U-100 insulin syringe, equal to around 0.23mL.

How many units is 1mg of TB-500?

If a 10mg vial is mixed with 3.0mL, 1mg is approximately 30 units on a U-100 insulin syringe, equal to around 0.30mL.

How long does one 10mg TB-500 vial last?

At 1mg daily, one 10mg vial contains around 10 administrations. At 500mcg daily, it contains around 20 administrations, although the reconstituted storage window still matters.

Is TB-500 the same as thymosin beta-4?

No. TB-500 is commonly discussed as a synthetic fragment related to the active region of thymosin beta-4, not the full thymosin beta-4 protein.

Is TB-500 approved for human use?

No. The source protocol notes that TB-500 is not FDA-approved for human administration and is for research purposes only.

Is TB-500 banned in sport?

Yes. The source protocol notes that TB-500 is prohibited in competitive sports under WADA regulations.

Is this a personal dosing recommendation?

No. This page is an educational reconstitution and measurement guide only. It is not medical advice or a personal protocol.

Related Resources

Leave a Reply

Your email address will not be published. Required fields are marked *

New Providers
Australian Research Peptides Review (2026)

Australian Research Peptides

Supplier Janoshik Reports Competitive Pricing 23+ Products Listed

Apex Lab Aus Review (2026)

Apex Lab Aus

Highly Competitive 10-Vial Bulk Packs Australian Retail Stock & Dispatch Testing Available on Request

NuVion Health Review (2026)

NuVion Health

11 Verifiable Janoshik Reports Australian Stock & Dispatch 30+ Research Products

Peptide Planet Review (2026)

Peptide Planet

Supplier BTLabs Reports Competitive Pricing 21+ Products Listed

PhaseOne Australia Review (2026)

PhaseOne AUS

Supplier Janoshik Reports Competitive Pricing 23+ Products Listed

Recent News